The Brave New World of Radiotherapeutics
As AI reshapes deeply specialized scientific work, R&D professionals must learn to navigate the shift to a skills-centered market. The key is knowing which skills to...
Following Insmed’s decision to hold off on launching a newly approved lung disease drug in Europe, experts anticipate more companies will do the same as they...
Phages have been known to trade chemical messages to guide their life‑cycle decisions, but new research shows that some of those messages function more like Trojan...
Nature Biotechnology, Published online: 01 April 2026; doi:10.1038/s41587-026-03051-1 ERAST speeds up homology search and provides a vector database for 1 billion biological sequences.
A pair of billion-dollar-plus buyout deals are in the works with Eli Lilly agreeing to acquire sleep disorder drug developer Centessa Pharmaceuticals for approximately $7.8 billion,...
Pharma goes on $25.5B, eight-day acquisition spree
Researchers headed by a team at the Icahn School of Medicine at Mount Sinai have identified and described a previously unknown recessive neurodevelopmental disorder (NDD) that...
FDA identifies eight deaths tied to Amgen's Tavneos
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...